245 related articles for article (PubMed ID: 35107380)
1. Development of Recombinant Infectious Hepatitis E Virus Harboring the nanoKAZ Gene and Its Application in Drug Screening.
Primadharsini PP; Nagashima S; Nishiyama T; Takahashi M; Murata K; Okamoto H
J Virol; 2022 Mar; 96(6):e0190621. PubMed ID: 35107380
[TBL] [Abstract][Full Text] [Related]
2. Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform.
Nagashima S; Primadharsini PP; Nishiyama T; Takahashi M; Murata K; Okamoto H
J Virol; 2023 Sep; 97(9):e0050823. PubMed ID: 37681960
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Hepatitis E Viruses Harboring Tags in the ORF1 Protein.
Szkolnicka D; Pollán A; Da Silva N; Oechslin N; Gouttenoire J; Moradpour D
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315997
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.
Nagashima S; Takahashi M; Kobayashi T; ; Nishizawa T; Nishiyama T; Primadharsini PP; Okamoto H
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878075
[TBL] [Abstract][Full Text] [Related]
5. Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses.
Yin X; Ambardekar C; Lu Y; Feng Z
J Virol; 2016 Apr; 90(8):4232-4242. PubMed ID: 26865708
[TBL] [Abstract][Full Text] [Related]
6. Three Distinct Reporter Systems of Hepatitis E Virus and Their Utility as Drug Screening Platforms.
Primadharsini PP; Nagashima S; Nishiyama T; Okamoto H
Viruses; 2023 Sep; 15(10):. PubMed ID: 37896767
[TBL] [Abstract][Full Text] [Related]
7. Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
Todt D; Friesland M; Moeller N; Praditya D; Kinast V; Brüggemann Y; Knegendorf L; Burkard T; Steinmann J; Burm R; Verhoye L; Wahid A; Meister TL; Engelmann M; Pfankuche VM; Puff C; Vondran FWR; Baumgärtner W; Meuleman P; Behrendt P; Steinmann E
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1731-1741. PubMed ID: 31896581
[TBL] [Abstract][Full Text] [Related]
8. Generation of a Bactrian camel hepatitis E virus by a reverse genetics system.
Zhang W; Ami Y; Suzaki Y; Doan YH; Takeda N; Muramatsu M; Li TC
J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34242156
[TBL] [Abstract][Full Text] [Related]
9. Ritonavir Blocks Hepatitis E Virus Internalization and Clears Hepatitis E Virus In Vitro with Ribavirin.
Primadharsini PP; Nagashima S; Takahashi M; Murata K; Okamoto H
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366538
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis E Virus Replication.
LeDesma R; Nimgaonkar I; Ploss A
Viruses; 2019 Aug; 11(8):. PubMed ID: 31390784
[TBL] [Abstract][Full Text] [Related]
11. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
[TBL] [Abstract][Full Text] [Related]
12. The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus.
Corneillie L; Lemmens I; Montpellier C; Ferrié M; Weening K; Van Houtte F; Hanoulle X; Cocquerel L; Amara A; Tavernier J; Meuleman P
Cell Mol Life Sci; 2023 Oct; 80(11):326. PubMed ID: 37833515
[TBL] [Abstract][Full Text] [Related]
13. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
14. Screening of novel drugs for inhibiting hepatitis E virus replication.
Nishiyama T; Kobayashi T; Jirintai S; Kii I; Nagashima S; Prathiwi Primadharsini P; Nishizawa T; Okamoto H
J Virol Methods; 2019 Aug; 270():1-11. PubMed ID: 31004661
[TBL] [Abstract][Full Text] [Related]
15. Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.
Capelli N; Marion O; Dubois M; Allart S; Bertrand-Michel J; Lhomme S; Abravanel F; Izopet J; Chapuy-Regaud S
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463960
[TBL] [Abstract][Full Text] [Related]
16. A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function.
Meister TL; Brüggemann Y; Nocke MK; Ulrich RG; Schuhenn J; Sutter K; Gömer A; Bader V; Winklhofer KF; Broering R; Verhoye L; Meuleman P; Vondran FWR; Camuzet C; Cocquerel L; Todt D; Steinmann E
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2202653119. PubMed ID: 35969792
[TBL] [Abstract][Full Text] [Related]
17. Open Reading Frame 4 Is Not Essential in the Replication and Infection of Genotype 1 Hepatitis E Virus.
Bai H; Ami Y; Suzaki Y; Doan YH; Muramatsu M; Li TC
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992492
[TBL] [Abstract][Full Text] [Related]
18. Characterization of virus‒host recombinant variants of the hepatitis E virus.
Paronetto O; Allioux C; Diméglio C; Lobjois L; Jeanne N; Ranger N; Boineau J; Pucelle M; Demmou S; Abravanel F; Chapuy-Regaud S; Izopet J; Lhomme S
J Virol; 2024 Jun; 98(6):e0029524. PubMed ID: 38712945
[TBL] [Abstract][Full Text] [Related]
19. The lysine residues within the human ribosomal protein S17 sequence naturally inserted into the viral nonstructural protein of a unique strain of hepatitis E virus are important for enhanced virus replication.
Kenney SP; Meng XJ
J Virol; 2015 Apr; 89(7):3793-803. PubMed ID: 25609799
[TBL] [Abstract][Full Text] [Related]
20. Roles of the genomic sequence surrounding the stem-loop structure in the junction region including the 3' terminus of open reading frame 1 in hepatitis E virus replication.
Cao D; Ni YY; Walker M; Huang YW; Meng XJ
J Med Virol; 2018 Sep; 90(9):1524-1531. PubMed ID: 29718575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
